Droxicam

Droxicam is an organic heterotricyclic compound that is 2H,5H-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-dioxide substituted at positions 3 and 5 by pyridin-2-yl and methyl groups respectively. A prodrug of piroxicam, it is used for the relief of pain and inflammation in musculoskeletal disorders including rheumatoid arthritis and osteoarthritis. Among its listed roles, it functions as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic, a prodrug, a platelet aggregation inhibitor, a cyclooxygenase 1 inhibitor and a hepatotoxic agent. It belongs to the class of pyridines and an organic heterotricyclic compound. Functionally, it is related to piroxicam. Droxicam is an oxicam non-steroidal anti-inflammatory drug and a prodrug of [DB00554]. It is used to reduce pain and inflammation in musculoskeletal disorders including rheumatoid arthritis and osteoarthritis. Its therapeutic use is listed as analgesics and antirheumatic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Droxicamum and Ombolan. Its PubChem CID is 65679.